These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 7131303

  • 1. Arrhythmogenic effects of toxic concentrations of the antiarrhythmic drug lorcainide on the isolated canine ventricle.
    Senges J, Rizos I, Brachmann J, Gao TL, Lengfelder W, Kübler W.
    J Pharmacol Exp Ther; 1982 Nov; 223(2):547-51. PubMed ID: 7131303
    [Abstract] [Full Text] [Related]

  • 2. Electrophysiological characteristics of lorcainide, a new antiarrhythmic drug.
    Solti F, Czakó E, Szatmáry L.
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):26-9. PubMed ID: 3957486
    [Abstract] [Full Text] [Related]

  • 3. Electrophysiological effects of a new antiarrhythmic agent, lorcainide, on the isolated cardiac muscle fiber as compared with disopyramide.
    Shigenobu K, Atoda H, Asano T, Kasuya Y.
    J Pharmacobiodyn; 1980 Dec; 3(12):677-85. PubMed ID: 7277183
    [Abstract] [Full Text] [Related]

  • 4. In vivo and in vitro antiarrhythmic and arrhythmogenic effects of N-acetyl procainamide.
    Dangman KH, Hoffman BF.
    J Pharmacol Exp Ther; 1981 Jun; 217(3):851-62. PubMed ID: 6164783
    [Abstract] [Full Text] [Related]

  • 5. Voltage- and time-dependent depression of maximum rate of depolarisation of guinea-pig ventricular action potentials by two new antiarrhythmic drugs, flecainide and lorcainide.
    Campbell TJ, Vaughan Williams EM.
    Cardiovasc Res; 1983 May; 17(5):251-8. PubMed ID: 6883400
    [Abstract] [Full Text] [Related]

  • 6. Effect of SUN 1165, a new potent antiarrhythmic agent, on the kinetics of rate-dependent block of Na channels and ventricular conduction of extrasystoles.
    Hattori Y, Hidaka T, Aisaka K, Satoh F, Ishihara T.
    J Cardiovasc Pharmacol; 1988 Apr; 11(4):407-12. PubMed ID: 2453743
    [Abstract] [Full Text] [Related]

  • 7. [Electrophysiologic effects of lorcainide (R 15889) in man].
    Touboul P, Atallah G, Kirkorian G.
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1333-40. PubMed ID: 6797372
    [Abstract] [Full Text] [Related]

  • 8. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P, Tegelkamp R, Osada N, Schimpf R, Wolpert C, Breithardt G, Borggrefe M, Eckardt L.
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [Abstract] [Full Text] [Related]

  • 9. [Effect of stretching on the action potentials of the human and rabbit ventricular myocardium].
    Shkliar TF, Markhasin VS, Savichevskiĭ MS.
    Biull Eksp Biol Med; 1987 Mar; 103(3):259-61. PubMed ID: 3548837
    [Abstract] [Full Text] [Related]

  • 10. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
    Aupetit JF, Bui-Xuan B, Kioueh I, Loufoua J, Frassati D, Timour Q.
    Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
    [Abstract] [Full Text] [Related]

  • 11. The canine virtual ventricular wall: a platform for dissecting pharmacological effects on propagation and arrhythmogenesis.
    Benson AP, Aslanidi OV, Zhang H, Holden AV.
    Prog Biophys Mol Biol; 2008 Mar; 96(1-3):187-208. PubMed ID: 17915298
    [Abstract] [Full Text] [Related]

  • 12. Cellular electrophysiological effect of terikalant in the dog heart.
    Biliczki P, Acsai K, Virág L, Tálosi L, Jost N, Biliczki A, Papp JG, Varró A.
    Eur J Pharmacol; 2005 Mar 14; 510(3):161-6. PubMed ID: 15763239
    [Abstract] [Full Text] [Related]

  • 13. Electrophysiological effects of lorcainide, a new antiarrhythmic drug. Observations in patients with and without pre-excitation.
    Bär FW, Farré J, Ross D, Vanagt EJ, Gorgels AP, Wellens HJ.
    Br Heart J; 1981 Mar 14; 45(3):292-8. PubMed ID: 7470342
    [Abstract] [Full Text] [Related]

  • 14. Lorcainide (R 15 889), a first review.
    Amery WK, Heykants JJ, Xhonneux R, Towse G, Oettel P, Gough DA, Janssen PA.
    Acta Cardiol; 1981 Mar 14; 36(3):207-34. PubMed ID: 7020313
    [Abstract] [Full Text] [Related]

  • 15. Effects of flecainide on contractile force and electrophysiological parameters in cardiac muscle.
    Schulze JJ, Knops J.
    Arzneimittelforschung; 1982 Mar 14; 32(9):1025-9. PubMed ID: 6890819
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.